Pharmacokinetics (PK) of eribulin mesylate in cancer patients (pts) with normal and impaired renal function.
Antoinette R. Tan
Research Funding - Eisai
John Sarantopoulos
No relevant relationships to disclose
Lucy Lee
Employment or Leadership Position - Eisai
Larisa Reyderman
Employment or Leadership Position - Eisai
Yi He
Employment or Leadership Position - Eisai
Martin S. Olivo
Employment or Leadership Position - Eisai
Sanjay Goel
Research Funding - Eisai